dexmedetomidine has been researched along with Left Ventricular Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, D; Han, H; Hu, J; Lu, L; Tao, G; Zhang, R; Zhu, J | 1 |
| Kulkarni, A; Price, G; Saxena, M; Skowronski, G | 1 |
| Kremer, MJ | 1 |
3 other study(ies) available for dexmedetomidine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Dexmedetomidine improves cardiac function and protects against maladaptive remodeling following myocardial infarction.
Topics: Animals; Apoptosis; Biomarkers; Biopsy; Cardiotonic Agents; Dexmedetomidine; Disease Models, Animal; Fibrosis; Male; Mice; Myocardial Infarction; Oxidative Stress; Superoxide Dismutase; Ventricular Dysfunction, Left; Ventricular Function; Ventricular Remodeling | 2019 |
Difficult extubation: calming the sympathetic storm.
Topics: Aged; Conscious Sedation; Device Removal; Dexmedetomidine; Humans; Hypertension; Hypnotics and Sedatives; Intubation, Intratracheal; Male; Myocardial Infarction; Propofol; Pulmonary Edema; Stress, Physiological; Sympathetic Nervous System; Tachycardia; Ventricular Dysfunction, Left | 2004 |
Dexmedetomidine as a sole sedating agent with local anesthesia in a high risk patient for axillofemoral bypass graft.
Topics: Anesthetics, Local; Conscious Sedation; Contraindications; Dexmedetomidine; Humans; Hypnotics and Sedatives; Patient Selection; Reperfusion; Risk Factors; Ventricular Dysfunction, Left | 2006 |